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ABSTRACT The USA300 North American epidemic (USA300-NAE) clone of methicillin-
resistant Staphylococcus aureus has caused a wave of severe skin and soft tissue in-
fections in the United States since it emerged in the early 2000s, but its geographic
origin is obscure. Here we use the population genomic signatures expected from
the serial founder effects of a geographic range expansion to infer the origin of
USA300-NAE and identify polymorphisms associated with its spread. Genome se-
quences from 357 isolates from 22 U.S. states and territories and seven other coun-
tries are compared. We observe two signiﬁcant signatures of range expansion, in-
cluding decreases in genetic diversity and increases in derived allele frequency with
geographic distance from the Pennsylvania region. These signatures account for ap-
proximately half of the core nucleotide variation of this clone, occur genome wide,
and are robust to heterogeneity in temporal sampling of isolates, human population
density, and recombination detection methods. The potential for positive selection
of a gyrA ﬂuoroquinolone resistance allele and several intergenic regions, along with
a 2.4 times higher recombination rate in a resistant subclade, is noted. These results
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are the ﬁrst to show a pattern of genetic variation that is consistent with a range
expansion of an epidemic bacterial clone, and they highlight a rarely considered but
potentially common mechanism by which genetic drift may profoundly inﬂuence
bacterial genetic variation.
IMPORTANCE The process of geographic spread of an origin population by a series
of smaller populations can result in distinctive patterns of genetic variation. We de-
tect these patterns for the ﬁrst time with an epidemic bacterial clone and use them
to uncover the clone’s geographic origin and variants associated with its spread. We
study the USA300 clone of methicillin-resistant Staphylococcus aureus, which was
ﬁrst noticed in the early 2000s and subsequently became the leading cause of skin
and soft tissue infections in the United States. The eastern United States is the most
likely origin of epidemic USA300. Relatively few variants, which include an antibiotic
resistance mutation, have persisted during this clone’s spread. Our study suggests
that an early chapter in the genetic history of this epidemic bacterial clone was
greatly inﬂuenced by random subsampling of isolates during the clone’s geographic
spread.
KEYWORDS epidemics, ﬂuoroquinolones, founder effects, genetic drift, population
genetics, range expansion
The ﬁrst known cases of infection caused by the USA300 clone of methicillin-resistantStaphylococcus aureus (MRSA) were from outbreaks of skin and soft tissue infections
(SSTIs) in a prison in Mississippi in November 1999 and in a sports team in Pennsylvania
in September 2000 (1–3). By 2002, SSTIs caused by USA300 had occurred across
the United States (3, 4). By 2008, this clone was the leading cause of SSTIs seen in
emergency departments and was an increasing cause of health care-associated blood-
stream infections (5–8). As of 2012, USA300 was the predominant MRSA from all
infection sites reported in multistate surveillance in the United States (9, 10). A notable
feature of USA300 infections, besides their aggressive course, is that healthy young
people without risk factors for health care-associated MRSA infections are often af-
fected. These types of infections were called community-associated MRSA infections
and had not been observed in such a volume prior to the emergence of USA300 (11).
The USA300 clone was originally deﬁned by a unique pulsed-ﬁeld gel electropho-
resis (PFGE) pattern (12) that occurs with other traits, including multilocus sequence
type 8, spa type t008, the presence of the staphylococcal chromosomal cassette mec
(SCCmec) type IV element and the arginine catabolic mobile element (ACME), and the
ability to express the Panton-Valentine leucocidin (PVL) (2, 13). In 2005, a PFGE proﬁle
and SCCmec variant of USA300 that lacked ACME was identiﬁed in northern South
America with clinical and epidemiological characteristics similar to those of the North
American clone (14, 15). Phylogenomic analysis demonstrated that the North American
epidemic (NAE) and South American epidemic (SAE) clones are monophyletic sister
clades that have caused parallel epidemics in the Americas (16). Export of both clones
to other continents has occurred sporadically (17–19).
Transmission of USA300-NAE is primarily through close person-to-person contact
such as within households and among other populations living under crowded con-
ditions and sharing personal items (3, 20, 21). Only limited phylogenomic clustering of
USA300-NAE isolates by neighborhoods, hospitals, and cities has been observed,
suggesting migration between these populations (20–23). Further use of a phylog-
enomic approach to reveal the origin and spread of USA300-NAE in the United States
has been hindered by sparse geographic sampling and the clone’s poorly resolved,
star-like phylogeny. Thus, despite the ongoing public health signiﬁcance of USA300-
NAE, the fundamental question of where it originated remains unanswered.
Here we infer the geographic origin of USA300-NAE through the use of genomic
signatures that are expected to occur when an origin population expands its geo-
graphic range by a series of smaller populations (24). These smaller populations
represent the expansion front and are subject to potentially strong genetic drift arising
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from their serial founding (i.e., sequential bottlenecking). Consequently, these smaller
populations are expected to have decreased genetic diversity and an increased derived
allele frequency, on average, with distance from the origin population (25–27). While all
epidemic bacterial clones will expand their geographic range to some degree, the
power to detect these genomic signatures will depend on many demographic factors,
including the expansion time, bottleneck sizes, and rates of migration between pop-
ulations (28–30). Results from several studies indicate that the most recent common
ancestor of USA300-NAE existed at least 7 years prior to the ﬁrst report of this clone in
the literature (16, 19–21), which might have allowed genetic diversity to build near its
origin population prior to the spread and establishment of geographically distant
populations.
With the resolution provided by genome sequencing, we observe two signiﬁcant
signatures of range expansion of USA300-NAE that independently outline the same
region of origin in the eastern United States. We demonstrate that these signatures are
genome wide and robust to potential confounders and analysis artifacts. Some unusual
polymorphisms accompanying the spread of this clone are also identiﬁed, which builds
upon prior work (20, 21). One major implication of our study is the realization that
genetic drift caused by geographic range expansion may play a large role in shaping
the genetic variation of bacteria, even for epidemic clones where a leading role for
natural selection may be presumed.
RESULTS
Phylogenomic delineation of the USA300-NAE clade. From 357 genome se-
quences of USA300 and closely related isolates (see Data Set S1 in the supplemental
material), a total of 4,109 biallelic single nucleotide polymorphisms (SNPs) and
2.16 Mbp of invariant sites were extracted from the nonrepetitive core genome. A
maximum-likelihood (ML) phylogeny with branch lengths corrected for recombinant
sequences and a time-stamped Bayesian phylogeny from nonrecombinant sequences
showed that 330 isolates were USA300-NAE, 9 were USA300-SAE, and 18 were early-
branching USA300 or non-USA300 (Fig. 1, circle 1; Fig. S1 in Text S1). The USA300-NAE,
SAE, and NAESAE clades each had 100% bootstrap and posterior probability support
on these trees. Relationships within the USA300-NAE clade had relatively poor support;
116 (35%) of 329 nodes on the ML phylogeny had 0.7 bootstrap support, and 162
(49%) of 329 nodes on the Bayesian phylogeny had 0.95 posterior probability.
Nonetheless, this clade’s very low rate of recombination ( per site 0.00003) indicated
that many features of its phylogeny were probably accurate (31). One prominent
feature, noted previously (19–21), was the presence of a monophyletic ﬂuoroquinolone
(FQ)-resistant subclade, which was deﬁned by resistance mutations in gyrA (encoding
Ser84Leu) and grlA (encoding Ser80Tyr) and represented 157 (48%) of 330 USA300-NAE
isolates (Fig. 1, circle 2; Fig. S1 in Text S1). Only 9 (5%) of 173 USA300-NAE isolates
outside this subclade had these resistance alleles. On the basis of an estimated
mutation rate of 6.15  107 substitutions/site/year (95% credibility interval, 5.53 
107 to 6.77 107) from the Bayesian analysis, the dates for the most recent common
ancestor of our sample of USA300-NAE and its FQ-resistant subclade were estimated to
be 1992 (1988 to 1996) and 1998 (1998 to 2000), respectively (Fig. S1 in Text S1); these
estimates were in good agreement with previous studies (16, 19–21). A phylogeo-
graphic analysis to infer the origin of USA300-NAE was inconclusive and was inﬂuenced
by oversampling of the Mississippi isolates (see Text S1).
Genetic structure of USA300-NAE populations. The relatively poor phylogenomic
resolution within the USA300-NAE clade motivated a population genomics approach.
When U.S. states and territories were treated as populations, 18 populations had
sample sizes of 6 isolates and a total of 2,599 biallelic, nonrecombinant SNPs. The
Montana, Hawaii, and Puerto Rico populations were subsequently excluded as genetic
or geographic outliers, though their inclusion did not qualitatively alter our conclusions
(Fig. S2; Table S1 in Text S1). Tajima’s D was negative for each of the remaining 15 U.S.
populations, which indicated an abundance of rare alleles, but statistical signiﬁcance
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largely followed sample size (Table 1). Overall patterns of genetic variation were similar
among the subset of recent isolates from later in the epidemic (2007 to 2011), which
represented 229 (86%) of 265 isolates from these 15 populations (Table S2 in Text S1).
Finally, while 1,413 SNPs were nonsynonymous (nSNPs) and 516 were synonymous
(sSNPs), the ratio of nSNPs to sSNPs (2.7) was close to the expected value of 2.9 under
a simple neutral model (32).
Spatial genetic structure was detected in pairwise comparisons of the 15 U.S.
populations by the signiﬁcant positive correlation between genetic differentiation
FIG 1 ML phylogeny of USA300 with branch lengths corrected for recombination by CFML. Branch color indicates bootstrap
support of the tipward node. Circle 1 indicates clades. Circle 2 indicates an FQ resistance mutation(s). The asterisk indicates
an isolate with a resistance mutation in gyrA but not grlA. Circle 3 indicates the geographic sources of isolation.
TABLE 1 Population genomic summary statistics for 15 populations of USA300-NAE
Population(s)
No. of
isolates
Avg pairwise
FSTa a Wa
Tajima’s
Da P (D  0)
Avg tip-to-tip
distanceb (105)
Sum of pairwise
 valuesc
All 15 265 0.0345 0.0112 0.1483 2.9279 0.0034 1.8617
MS 33 0.0350 0.0085 0.0238 2.4578 0.0139 1.4748 2.5384
CA 29 0.0471 0.0094 0.0245 2.4000 0.0164 1.5681 0.8437
IL 27 0.0205 0.0104 0.0331 2.7086 0.0068 1.6446 0.1011
NY 25 0.0288 0.0119 0.0311 2.4655 0.0137 1.846 1.1768
NE 22 0.0431 0.0117 0.0225 1.9546 0.0506 1.8624 0.0964
TX 21 0.0266 0.0104 0.0255 2.4299 0.0151 1.6183 0.0379
OH 17 0.0291 0.0151 0.032 2.2684 0.0233 2.1435 2.3722
PA 17 0.0244 0.0124 0.0255 2.2082 0.0272 1.8791 1.1698
GA 16 0.0200 0.0133 0.0278 2.2684 0.0233 1.9802 1.69
FL 14 0.0197 0.0096 0.0201 2.3475 0.0189 1.4509 0.7842
IA 11 0.0269 0.0099 0.0156 1.7511 0.0799 1.5167 0.5411
OR 11 0.0665 0.0095 0.0138 1.5072 0.1318 1.4318 0.4013
MA 9 0.0238 0.0131 0.0183 1.4688 0.1419 1.8973 1.2202
WA 7 0.0643 0.0079 0.0088 0.5311 0.5953 1.2155 3.2673
SC 6 0.0411 0.0116 0.0133 0.8322 0.4053 1.6125 0.7896
aThe average pairwise FST, ; W, and D values were based on 2,599 biallelic, nonrecombinant SNPs.
bThe average tip-to-tip distance reﬂects branch lengths on an ML tree corrected for recombinant sites.
cThe sum of pairwise  values was based on 2,595 biallelic, nonrecombinant SNPs where ancestral and derived alleles were assigned.
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(Hudson’s ﬁxation index [FST]) and geographic distance (great-circle distance) (Mantel
r  0.397, P  0.0096, n  105 pairs; Table 2). Of the 19 pairwise comparisons with
signiﬁcant differentiation, 14 (74%) involved the West Coast states California, Oregon,
and Washington (Table S3 in Text S1). Among recent isolates, spatial genetic structure
was also detected (Table 2) and 12 (60%) of 20 pairwise comparisons with signiﬁcant
differentiation involved the West Coast states (Table S3 in Text S1). Spatial genetic
structure was also detected with alternative measurements of genetic differentiation
such as Weir and Cockerham’s FST, which was identical to ST with our data (Table S4 in
Text S1). Recent work has shown that spatial patterns of rapidly spreading infectious
diseases can sometimes be better informed by the connectedness of populations rather
than their physical geographic distance (33, 34). As measurements of population
connectedness, we examined total numbers of airline passengers and total migration
of residences between U.S. states (see Materials and Methods). Total numbers of airline
passengers performed better than total numbers of migrants as a predictor of genetic
differentiation, but geographic distance remained the most signiﬁcant predictor of
genetic differentiation, even after correction for total numbers of airline passengers
(Table 2). Thus, geographic distance was used for subsequent spatial analysis.
Evidence for range expansion of USA300-NAE from an eastern U.S. origin. The
spatial genetic structure described above is referred to as “isolation by distance” and
can occur with older populations at migration-drift equilibrium and with nonequilib-
rium populations that have undergone a recent range expansion (35). To speciﬁcally
test for a range expansion and to infer the origin of USA300-NAE, we examined the
expected signatures of decreased genetic diversity, as measured by  and average
tip-to-tip distance on the ML tree, and increased derived allele frequency, as measured
by the directionality index , with geographic distance from the origin. The origin was
inferred as the population with the most negative or most positive correlation when
genetic diversity or derived allele frequency, respectively, was regressed against the
geographic distance from that population (see Materials and Methods). Pennsylvania
was the most likely origin on the basis of a decrease in  (Pearson r  0.697, P 
0.0019, the probability of getting a correlation as extreme as the observed correlation
under a null hypothesis of panmixia [Pperm]  0.024, n  15), a decrease in tip-to-tip
distance (Pearson r  0.684, P  0.0025, Pperm  0.031, n  15), and an increase in
 by linear regression (Pearson r  0.667, P  0.0033, Pperm  0.029, n  15), but the
adjacent population of New York was the origin when the nonlinear regression of 
was used (Pearson r  0.686, Pperm  0.029, n  15) (Fig. 2A to C; Table S5 in Text S1).
Restriction of the analysis to recent isolates resulted in Pennsylvania as the origin with
each signature and with even stronger correlations than with all of the isolates (Fig. 2D
to F; Table S6 in Text S1). A clear East-to-West gradient of these correlations was
observed (Fig. 2). The West Coast states presented patterns that are the opposite of
TABLE 2 Relationships among genetic differentiation, geographic distance, and
connectivity from all pairwise comparisons of 15 populations of USA300-NAE
Testa and predictor of genetic distance
All isolates
(20012011)
Recent isolates
(20072011)
r P r P
Mantel
Geographic distance 0.397 0.0096 0.355 0.0187
Log total airline passengers 0.330 0.0732 0.384 0.0408
Log total migrants 0.210 0.1656 0.257 0.1112
Partial Mantel
Geographic distance accounting for log
total airline passengers
0.371 0.0245 0.325 0.0585
Log total airline passengers accounting
for geographic distance
0.297 0.0974 0.357 0.0630
aThe Mantel and partial Mantel tests were performed with 10,000 permutations.
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those expected of an origin; increased genetic diversity and decreased derived allele
frequency occurred with distance from the West Coast (Tables S5 and S6 in Text S1).
We also examined whether USA300-NAE genetic diversity could be explained by
human population density. Variation in human population density, which is analogous
to variation in the carrying capacity of USA300-NAE, as humans are the natural host of
this clone, is expected to make the detection of a range expansion more difﬁcult (27,
36). Human population density data for the years 2000 and 2010 showed a signiﬁcant
positive correlation with  (year 2000, Pearson r 0.464, P 0.041, n 15; year 2010,
Pearson r  0.450, P  0.046, n  15), but not with tip-to-tip distance or . In a
multivariate analysis of the decrease in  with the distance from Pennsylvania and
accounting for human population density, the range expansion signature remained
signiﬁcant (year 2000, adjusted r  0.652, P  0.014, n  15; year 2010, adjusted r 
FIG 2 Signatures of range expansion and the origin of USA300-NAE. Panels A to C show the regressions of , tip-to-tip distance, and , respectively, with
geographic distance from Pennsylvania, when all isolates (from 2001 to 2011) were used. A solid line indicates the linear regression, and dotted lines indicate
the 95% conﬁdence intervals. The maps in panels A to C illustrate the correlations when each of the 15 populations was used as the origin, with interpolation
of values between populations. Stronger evidence of origin is shown as yellow. Panels D to F show the results obtained when only recent isolates (from 2007
to 2011) were used. The asterisks on the maps in panels C and F indicate the coordinates of the selected origin when the nonlinear regression of  was used.
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0.650, P 0.015, n 15) and human population density was not a signiﬁcant covariate
(year 2000, P  0.493; year 2010, P  0.512). In summary, these results show a pattern
of USA300-NAE genetic variation that is consistent with a process of geographic range
expansion from an eastern U.S. origin that cannot be explained by heterogeneity in the
temporal sampling of isolates or by human population density.
Additional studies of the USA300-NAE range expansion signatures. As a neutral
demographic process, range expansion is expected to produce signatures across the
genome. Although the two signatures of range expansion described above represent
averages across SNPs, additional studies were done to conﬁrm their genome-wide
distribution. First, we separately studied the 1,413 nSNPs and the 516 sSNPs. These
subsets of SNPs each gave an eastern origin of USA300-NAE, with Pennsylvania, Ohio,
or Massachusetts as the origin, depending on the signature (Tables S7 and S8 in
Text S1). Next, we randomly downsampled SNPs to gain insight into the minimum
number of SNPs necessary to detect the eastern origin of USA300-NAE. Randomly
downsampling to 1,300 and 780 SNPs for tests based on a decrease in  and an
increase in, respectively, gave an origin in the Pennsylvania region (i.e., Pennsylvania,
Ohio, New York, or Massachusetts) at least 80% of the time, but the signatures rapidly
decayed with further downsampling (Fig. 3). These ﬁndings veriﬁed that the signatures
of the USA300-NAE range expansion were genome wide.
Evidence for allele surﬁng of an FQ resistance allele. Most derived alleles are
expected to stay at a low frequency or go extinct during a range expansion because of
the cumulative genetic drift caused by the serial founding of smaller populations along
the expansion front (25). On rare occasions, a derived allele can persist through these
serial founder events and reach a high frequency—this phenomenon is referred to as
“allele surﬁng” (37). Alleles can surf regardless of their ﬁtness effects, since strong
genetic drift limits the efﬁcacy of natural selection, but ﬁtness can impact the long-term
FIG 3 Power analysis of signatures of range expansion. USA300-NAE SNPs were randomly downsampled
to make 20 new data sets for each bin of downsampled SNPs and tested for a signiﬁcant origin by using
the signature of a decrease in  (panel A) or an increase in  (panel B). Yellow represents those data
sets giving a signiﬁcant origin in the Pennsylvania region (i.e., Pennsylvania, Ohio, New York, or
Massachusetts), red represents any other signiﬁcant origin, and white represents a nonsigniﬁcant origin.
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behavior of surﬁng alleles. For example, simulations indicate that in the colonized areas
behind the expansion front, advantageous alleles tend to increase in frequency and can
initiate a second expansion front from their own origin population (24, 38).
To detect allele surﬁng, we focused our study on SNPs with well-sampled derived
alleles. As found in previous simulations of range expansion (37), only a small fraction
of derived alleles were well sampled (Fig. 4A, black dots); 18 of 2,595 (0.7%) derived
alleles were sampled from 10 or more populations at frequencies averaging10%. The
same trend occurred when only recent isolates were considered (Fig. 4A, red dots) and
when allele frequencies were binned to better control for unequal sample sizes among
populations (Fig. 4A, blue dots). Frequency gradients were also rarely detected, as
expected from simulations (37). Only 2 of these 18 well-sampled alleles had signiﬁcant
frequency gradients that were robust to the different sampling schemes and the
false-discovery rate (FDR) (Table 3). These two alleles resulted from a nonsynonymous
mutation in gyrA (Ser84Leu) with a positive gradient from Illinois (all isolates, Pearson
r  0.528, P  0.02; recent isolates, Pearson r  0.643, P  0.0008; binned allele
frequencies, Pearson r  0.514, P  0.018; all FDR-corrected P values with n  15;
Fig. 4B) and a synonymous mutation in ssa-1, which encodes staphylococcal secretory
antigen 1, with a positive gradient from Mississippi or Texas, depending on the
sampling scheme (all isolates, Pearson r  0.690, P  0.02; recent isolates, Pearson r 
0.720, P  0.0075; binned allele frequencies, r  0.643, P  0.018; all FDR-corrected
P values with n  15; Fig. 4C). The gyrA allele was the only well-sampled allele to also
have a signiﬁcant positive gradient with distance from the Pennsylvania region (not
shown). No correlation was detected between the gyrA allele frequency gradient and
state-wide estimates of FQ use in humans (Table S9 in Text S1); thus, there is currently
no evidence that the gyrA allele frequency gradient was induced by an environmental
gradient.
It is important to note that the signatures of USA300-NAE range expansion do not
depend on the gyrA allele (Table S10 in Text S1) and that the signatures predate the
origin of the FQ-resistant subclade since a separate analysis with the isolates outside
this clade also best supports an eastern origin (Table S11 in Text S1). In summary, a
small number of successful alleles do not dominate the overall signature of an in-
creased derived allele frequency; rather, the signature results from the more numerous
mid- and low-frequency alleles that may expand geographically in more limited pulses.
FIG 4 Identiﬁcation of well-sampled derived alleles of USA300-NAE. Panel A shows the relationship between the frequency of derived
alleles and the number of colonized populations when all isolates (from 2001 to 2011; black dots), recent isolates (from 2007 to 2011; red
dots), or all isolates with allele frequencies binned into one of ﬁve 20% bins before averaging across populations (blue dots) were used.
Panels B and C show the signiﬁcant positive frequency gradients for the gyrA and ssa-1 alleles, respectively. The data points, regression
lines, and 95% conﬁdence intervals are shown for all isolates (in black) along with the regression lines for recent isolates (red lines) and
for all isolates with binned allele frequencies (blue lines). The different origin populations giving the best correlation with the different
analyses are indicated in panel C.
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The gyrA allele may provide a rare example of an advantageous allele with two modes
of spread during the USA300-NAE range expansion: one on the expansion front of
USA300-NAE and the other centered on Illinois.
Inﬂuence and patterns of recombination. The different model-based methods of
ClonalFrameML (CFML) (39) and BratNextGen (BNG) (40) were used to detect recom-
bination. In the full sample of 357 genomes, recombinant regions spanned 618 (15%)
of 4,109 SNPs by CFML analysis, 574 (14%) of 4,109 SNPs by BNG analysis, and 493 (12%)
of 4,109 SNPs by both methods (Fig. 5A). The inference of USA300-NAE’s origin
described above was done after the removal of recombinant SNPs identiﬁed by CFML
analysis (except for the average tip-to-tip distance that used recombination-corrected
branch lengths). A similar result was obtained after the removal of recombinant SNPs
identiﬁed by BNG analysis; in this case, Pennsylvania and the adjacent populations of
Ohio and New York were the origins, depending on the signature (Table S12 in Text S1).
Thus, the inferred eastern origin of USA300-NAE was robust to two different methods
for detecting recombination. Of note, the inferred origin was decisively inﬂuenced by
the presence of recombination. When all recombinant SNPs were included in the
analysis, Florida was the origin with each signature (Table S13 in Text S1). Of the 10
branches on the ML phylogeny of USA300-NAE that were affected the most by
recombination, 6 led to isolates exclusively from the southeastern United States. These
results indicate that importation of divergent alleles into speciﬁc populations can, on
average, increase their genetic diversity and decrease their derived allele frequency
(possibly by displacing derived alleles with ancestral alleles). Thus, recombination
detection is a crucial part of the analysis.
Two additional observations about recombination were made. First, some nucleo-
tide sites were recombined more often than expected under the CFML model, espe-
cially those sites that had recombined in three or more branches of the phylogeny
(Fig. 5B). Nearly all of these sites were intergenic, and transfer was not limited to
USA300-NAE branches for two of these six loci (Table 3). The average tract length
(standard deviation) of all recombinations was 83 (121) bp, which is shorter than that
described at the species level for S. aureus (183 bp in reference 39 and 654 bp in
reference 41). It is possible that the homoplasious distribution of some of these sites on
the phylogeny has resulted from recurrent mutation rather than recurrent recombina-
TABLE 3 Unusual SNPs from various population genomic analyses
Category and TCH1516a chromosome
coordinate(s) TCH1516 locus, gene Comment
SNPs that are polymorphic in both USA300-NAE
and USA300-SAE clades
460 Intergenic before 0001
14575 Intergenic 0008–0009
233245 Coding 0210, hypothetical protein nSNP
2542210 Intergenic 2401–2402
SNPs with derived allele present in 10 populations
with 10% average frequency and a
signiﬁcant frequency gradient
7282 Coding 0006, gyrA nSNP
2708710 Coding 2561, ssa-1 sSNP
SNPs within intervals that were recombined
more often than expected under the CFML
recombination model
168833–169219 Intergenic 0159–0160 Recombined on 3 or 4 branches
672683–672727 Intergenic 0614–0615 Recombined on 3 or 4 branches
2600705 Intergenic 2461–2462 Recombined on 3 branches
2600727–2600792 Intergenic 2461–2462 Recombined on 3 or 4 branches
2680141–2680194 Intergenic 2536–2537 Recombined on 8 or 9 branches
2813570–2813582 Coding 2564, sraP Recombined on 4 branches
aThe TCH1516 locus designation has the preﬁx USA300HOU_.
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tion, but their unusualness under the model indicates that they could be the result of
positive selection. Second, the ratio of recombination to mutation events was 2.4 times
as high in the FQ-resistant subclade of USA300-NAE as that in isolates outside this
subclade that were largely FQ susceptible. The / ratio (95% credibility interval) was
0.029 (0.022 to 0.38) for the FQ-resistant subclade and 0.012 (0.007 to 0.018) for the
other isolates, despite similar population-scaled mutations rates () of 0.00074 and
0.00077, respectively. Thus, diversiﬁcation by recombination of core genome sequences
has been higher in the FQ-resistant subclade than in the rest of USA300-NAE.
DISCUSSION
Population genomics provides a complementary approach to phylogenomics when
studying the origin and spread of pathogens. The serial founder model of range
expansion is a population genetic model that has been used previously to infer an
African origin of human populations (42, 43) and the afﬁliated microbial pathogens
Helicobacter pylori and Plasmodium falciparum (44, 45). Through genome sequencing,
we were able to extend this approach to study the much more recent origin and
continental spread of the USA300-NAE clone.
Approximately half of the core nucleotide variation in USA300-NAE can be explained
by geographic distance from Pennsylvania: 47 to 49% of the variation when considering
all isolates and 54 to 63% of the variation when considering only recent isolates
(Tables S5 and S6 in Text S1). Since it is the cumulative genetic drift caused by serial
founding of smaller populations along the expansion front that is ultimately respon-
sible for the signatures of range expansion (42), these correlations may provide an
estimate of the impact of genetic drift in shaping USA300-NAE’s genetic variation. In
general, the relative contribution of drift compared to other population processes that
affect bacterial genetic variation is poorly understood outside certain contexts, such as
obligate intracellular bacteria (46). Our results highlight a rarely considered but poten-
tially common mechanism whereby drift may signiﬁcantly impact bacterial genetic
variation. All epidemic bacterial clones will expand their geographic range to some
FIG 5 Recombination in USA300. Panel A shows 4,109 biallelic SNPs in columns and results of recombination
analysis by CFML and BNG in rows. Gray columns indicate nonrecombinant SNPs according to both
methods. White columns indicate recombinant SNPs according to both methods. Black columns indicate
recombinant SNPs according to one method only. Panel B shows the distribution of the number of
branches for which sites are recombinant as inferred by CFML (Œ) and as expected under the CFML
model (). In panel B, 95% conﬁdence intervals are shown but the intervals are sometimes too small to
be visible and sometimes the symbols for observed and expected results overlap.
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degree, but the signatures of range expansions may not always be detectable because
of their dependence on demographic factors (28–30) that may differ among bacteria.
Nonetheless, the drift that occurs during range expansion may have important long-
term consequences for bacteria, such as an initially reduced capacity to respond to
selection.
One limitation of our study was the lack of precise geographic coordinates of
isolates within U.S. states that likely lowered the precision of the correlations noted
above. In addition, although our study provides the most geographically diverse
sample of USA300-NAE examined by genome sequencing to date, it is still a relatively
sparse sample of U.S. populations. Even so, our results were sufﬁcient to rule out
potential confounders such as temporal differentiation and human population density
as causes of the patterns observed.
While Pennsylvania was the most likely origin among our sampled populations in
most analyses, the nearby populations of Ohio, New York, and Massachusetts were the
most likely origins in certain subsets of analysis and ranked highly in most analyses.
Considered together, our results strongly indicate that the origin of USA300-NAE is in
the eastern and not the western United States. In fact, our results are incompatible with
a West Coast origin of USA300-NAE. California, Oregon, and Washington populations
had relatively high genetic differentiation, low genetic diversity, and a high derived
allele frequency, which are expected at the edge of an expanding population and not
at its origin. The result for the outlier population Hawaii was similar to that for the West
Coast populations (Table S1 in Text S1). Therefore, our results do not validate anecdotes
(47) or an analysis of the geographic center of publications on USA300 (48) that favor
a shift from the West and Midwest toward the East. However, it is also important to
point out that we have speciﬁcally characterized the origin and spread of the USA300-
NAE clade, which has been the major cause of infections during this epidemic.
Rarely, a derived allele may propagate throughout a range expansion—this phe-
nomenon has been called “allele surﬁng” (37) and has not been observed previously in
natural populations of bacteria, to our knowledge. Hallatschek et al. (49) showed that
the familiar process of sectoring of bacterial colonies on agar plates represents a
laboratory version of allele surﬁng. Here, only two derived alleles individually had
convincing positive frequency gradients consistent with some form of allele surﬁng.
One of these alleles is from a silent mutation in ssa-1 and is likely neutral, whereas the
other is an FQ resistance allele in gyrA and likely confers a selective advantage. These
ﬁndings also provide an explanation for a previous observation that FQ resistance may
be less common in USA300 from Illinois than in USA300 from the East and West coasts
(21)—because Illinois is nearer the origin of the FQ resistance allele and the higher
frequencies were achieved as its own range expanded (Fig. 4B).
As a cautionary note, recombination of divergent alleles into some populations
along an expansion front can introduce an artifact into the analysis. Thus, we focused
on biallelic, nonrecombinant SNPs and demonstrated robustness of results to two
different model-based methods for detecting recombination. For this same reason, we
excluded accessory gene variation as a source of information for inferring origin. Our
study used a broader geographic sample of USA300-NAE within the United States and
detected more recombination than prior studies have (20, 21, 23), especially among
isolates from the southeastern United States that have been poorly sampled in prior
studies. In addition, we found that the FQ-resistant subclade of USA300-NAE had a
higher recombination rate than the rest of USA300-NAE. The potential association
between FQ resistance and recombination might be explained by molecular genetic
and/or population genetic mechanisms. For example, FQs may stimulate recombina-
tion pathways in S. aureus, as observed in Escherichia coli (64), and the FQ-resistant
strains would have a better ability to survive exposure to the antibiotic. Alternatively,
import of divergent alleles along an expansion front may reﬂect the reduced efﬁcacy of
selection in serially founded populations, as observed in simulations and empirical
studies of range expansion (24), and is more evident in the slightly more recently
founded FQ-resistant subclade than in the rest of USA300-NAE.
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In summary, our results narrow the geographic region of the origin of USA300-NAE
to the eastern United States, speciﬁcally the Pennsylvania region, and identify several
unusual polymorphisms that have persisted through the sequential bottlenecking of
this clone’s spread across the United States. New results extend previous observations
(20, 21) that underscore the importance of FQ resistance in the evolution of USA300-
NAE. Finally, our study suggests that the genetic drift attributed to geographic range
expansion can be a potent evolutionary force in bacteria.
MATERIALS AND METHODS
Bacterial isolates. A total of 357 isolates from 22 U.S. states and territories and seven other countries
(Argentina, Australia, Columbia, Denmark, Ecuador, Germany, and Ireland) were included in this study
(Data Set S1). All isolates were determined to be USA300 or closely related by screening (or rescreening)
for the spa type and the presence of mecA and PVL-associated genes by previously described methods
(50). Ciproﬂoxacin susceptibility testing was done by standard disk diffusion methods (65). Over half of
the isolates, 191 (54%) of 357, were from two surveys of MRSA diversity in the United States (51); these
isolates were collected from 81 nasal and 110 blood specimens from unique patients in 15 states in 2009
to 2011. The remaining isolates were selected to increase sample sizes or to provide a sample for seven
states and Puerto Rico (103 isolates), were early reference isolates from the United States (26 isolates), or
were international isolates (36 isolates). In addition, the reference genome sequence of strain TCH1516
(52) was included. The genomes of 322 isolates were newly sequenced, and those of 35 isolates were
from a prior study (16).
Genome sequencing, alignment, and assembly. Sequencing was performed with Illumina (San
Diego, CA) MiSeq instruments. Genomic DNA was isolated with Qiagen DNeasy Blood and Tissue kits.
Sequencing libraries were prepared with Illumina Nextera XT DNA sample preparation kits (250-bp
paired-end reads). MiSeq Reporter was used to demultiplex and trim adapters from the sequence reads.
CLC Genomics Workbench v7 (Qiagen, Aarhus, Denmark) was used to ﬁlter reads for minimum quality
(base quality, Q13; number of ambiguities, 2; read length, 15 bp), align reads with the reference
genome of strain TCH1516, exclude ambiguously aligned and duplicate reads, and assemble genomes de
novo. Read and assembly information for each genome is presented in Data Set S1.
Variant calling, ﬁltering, and functional assignment. Aligned reads were coordinate sorted,
realigned around insertion-deletion polymorphisms (indels), and compressed in size with Picard v1.85
and GATK v2.3.9 (53). Repetitive regions of 50 bp with 80% nucleotide identity, identiﬁed through a
pairwise megablast search of the reference genome against itself, and ﬁve known mobile genetic
elements were excluded from variant calling. Multiallelic and biallelic SNPs and indels were called with
GATK. Variants with a base quality of Q30, a read depth of 3, and a base “homozygosity” of 75%
in all genomes were retained. SnpEff v4 (54) was used with the annotation of the reference genome to
assign functional effects to the variants. The invariant core was ﬁltered to the same stringency as the
variants and was merged with the ﬁltered biallelic SNPs to produce a multi-fasta alignment that was used
for phylogenomic analysis and recombination detection.
Phylogenomic analysis and recombination detection. An ML phylogeny was generated with
PhyML v3.0 (55) under an HKY   substitution model. Subtree pruning and a regrafting search of the
tree space were performed with a BioNJ starting tree and 10 random starting trees. Node support was
evaluated by using 100 bootstrap replicates. To detect recombinant sequences, estimate recombination
parameters, and correct branch lengths, CFML (39) was used with the ML phylogeny and default
parameters under its standard model. BNG (40) was used to detect recombinations with a run of 20
iterations, and the signiﬁcance of the recombinant segments was determined with 100 permutations and
a cutoff P value of 0.05.
A time-stamped Bayesian phylogeny was generated with BEAST v1.7.5 (56) under an HKY  
substitution model and an uncorrelated lognormal relaxed molecular clock. For these analyses, nonre-
combinant sequences were used. Two demographic models were considered, a constant-size coalescent
model and a Bayesian skyline model. For each model, Markov chain Monte Carlo chains were run four
times, each run for 200 million steps with sampling every 20,000 steps. Convergence and mixing were
checked with Tracer v1.5. Runs were combined after the removal of 10% of the samples as a burn-in with
LogCombiner v1.7.5. The Bayesian skyline model was a better ﬁt (Bayes factor, 4.82) and was therefore
used for this study. A maximum clade credibility tree was generated with TreeAnnotator v1.7.5.
Population genomic analysis. Genetic differentiation between populations was measured with
Hudson’s FST (57) across biallelic, nonrecombinant SNPs and the signiﬁcance of pairwise FST values was
tested with 10,000 permutations and a Bonferroni P value. Principal-component analysis of the pairwise
FST matrix was done with the princomp function of the built-in R stats package (58). Geographic distance
between populations was measured by using the haversine great-circle distance (in kilometers) between
the centers of U.S. states and territories with the R package geosphere (58). The numbers of airline
passengers and migrants between U.S. states were obtained from the U.S. Bureau of Transportation
Statistics (https://www.transtats.bts.gov/Fields.asp?Table_ID310) and the U.S. Census Bureau (https://
www.census.gov/data/tables/time-series/demo/geographic-mobility/state-to-state-migration.html), re-
spectively. The comparisons of all isolates (2001 to 2011 isolation dates) were done by using 2001 to 2011
passenger data and 2005 to 2011 (earliest available) migrant data, whereas the comparisons of recent
isolates (2007 to 2011 isolation dates) used 2007 to 2011 passenger and migrant data. The numbers of
passengers or migrants, respectively, between any two U.S. states are asymmetrical and can differ by
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orders of magnitude but are signiﬁcantly correlated (passengers, Pearson r  0.999, P  2.2e-16;
migrants, Pearson r  0.843, P  2.2e-16; two-tailed test with n  105 pairs), so (log) totals were used.
Mantel and partial Mantel tests with 10,000 permutations were performed with the R package ecodist
(59).
Given the evidence for nonequilibrium populations, we ﬁrst validated appropriate measurements of
genetic diversity to study range expansion. Watterson’s estimator (w), which is more sensitive to recent
mutations (60), was correlated with sample size (Pearson r  0.707, P  0.003, two-tailed test with n 
15) and was therefore inappropriate for our study since the diversity would reﬂect sample size rather
than distance from the origin. Average pairwise difference (), which is more sensitive to older
mutations (60), was uncorrelated with sample size (Pearson r0.135, P 0.63, two-tailed test with n
15) and was therefore used in our study. The average tip-to-tip (patristic) distance on the ML tree, which
is analogous to , was also uncorrelated with sample size (Pearson r  0.119, P  0.67, two-tailed test
with n  15) and was used in our study. Nucleotide diversity and Tajima’s D were calculated with the R
package pegas (61), whereas tip-to-tip distance was calculated with the R packages ape (62) and
phangorn (63). The origin was inferred by linear regression as the population with the most negative
correlation between genetic diversity and geographic distance from the origin (42, 44) with the built-in
R stats package (58). A separate analysis to estimate Pperm was obtained by randomly shufﬂing isolates
between populations and determining the best origin 1,000 times. For graphic display of results,
correlations between sampling points were interpolated by kriging with ArcGIS v10.2.2 (ESRI, Redlands,
CA) with the Spatial Analyst Toolbox and a default grid size of 0.78.
To study derived allele frequency, we ﬁrst polarized the ancestry of alleles in USA300-NAE by using
the USA300-SAE sister clade as an outgroup and assigning the allele common to both clades as ancestral
and the allele unique to USA300-NAE as derived. Four biallelic, nonrecombinant SNPs were polymorphic
in both clades and thus were excluded (Table 3). The directionality index () was then calculated by
using the R source code modiﬁed from the rangeExpansion package (27).  is a pairwise measurement
of the difference in average derived allele frequency between populations i and j.  is negative when
population i is closer to the origin and positive when population j is closer to the origin.  is zero when
the populations are the same distance from the origin and when there is no range expansion. For each
pair of populations, only derived alleles present in both populations were used and sample size
differences were handled by repeatedly downsampling to the smallest sample size in the pair. The origin
was inferred by nonlinear regression as the population with the most positive correlation between and
the distance from the origin (27). In addition, we report the origin inferred from a linear regression
between  and the distance from the origin, along with Pperm from the 1,000 data sets where isolates
were randomly shufﬂed between populations.
To test the relationship between human population density and signatures of range expansion, we
used population density data for the years 2000 and 2010 from the U.S. Census Bureau (https://www
.census.gov/2010census/data/apportionment-dens-text.php). A multivariate regression analysis of nucle-
otide diversity with distance from Pennsylvania was performed with the built-in R stats package (58) with
population density as a covariate. The P values reported in population genomic analyses were one tailed,
unless otherwise noted, because speciﬁc positive or negative relationships were being tested. For the
ﬁner-scale study of derived allele frequency, the FDR was controlled with the Benjamini-Hochberg
correction of P values with the p.adjust function of the built-in R stats package (58).
Accession number(s). The sequence reads obtained in this study were submitted to the NCBI
Sequence Read Archive (BioProject PRJNA330544).
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